• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

U.S. Department of Justice

Judge banging gavel on stack of money
Pharma

Gilead, US government resolve long-running HIV patent dispute

Gilead has settled with the U.S. government to resolve the feds’ last-ditch appeal.
Kevin Dunleavy Jan 16, 2025 10:48am
A gavel in the foreground with the scale of justice in the background

Glenmark settles with US over longstanding price-fixing claims

Sep 5, 2024 1:31pm
Gilead

US appeals Gilead's trial win in Truvada, Descovy patent fight

Jul 9, 2024 11:00am
handcuffs prosecution criminal charges

Merck KGaA's MilliporeSigma helps expose fraud scheme to DOJ

May 22, 2024 12:48pm
Regeneron

DOJ sues Regeneron for under-reporting Eylea price to Medicare

Apr 11, 2024 11:12am
FTC

FTC to review Novo Holdings' Catalent buyout for 30 more days

Apr 8, 2024 11:58am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings